Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
MIB1 index useful as marker of chemotherapy response
February 17th, 2005
The MIB1 index can be used to assess the response to chemotherapy in breast cancer patients. In a recent study, scientists in the United States "determined the extent of variation in proliferative markers and hormone receptor status in breast carcinoma between core biopsies and subsequent resections, and determined the impact of clinical and histologic parameters on such variation." "We performed a paired comparison of biomarkers in 87 core biopsies and subsequent resections of breast carcinomas in patients with and without preoperative chemotherapy," explained S. Sharma and coauthors at the University of Texas Southwestern Medical Center. "The...
Source: Women's Health Weekly (2005-02-17)
|
